Co-circulation of Three HTLV-2 Subtypes and Distinct Immune signatures in Asymptomatic People Living with HTLV in the Western Brazilian Amazon
Abstract Background HTLV is endemic in the Brazilian Amazon, but the diversity of circulating strains in Amazonas remains poorly characterized, and it is still unclear whether asymptomatic carriage is associated with a distinct systemic immune profile. We combined phylogenetic characterization with serum cytokine and chemokine profiling to address both questions. Methods Forty prospective blood donors with confirmed HTLV-1/2 infection and 30 HTLV-negative blood donors were included. The 5′ LTR region was amplified by nested PCR, and 40 amplicons underwent Sanger sequencing and maximum-likelihood phylogenetic analysis. Serum cytokines, chemokines, and growth factors were quantified by multiplex immunoassay. Immune profiles were evaluated using univariate comparisons, correlation analysis, principal component analysis, PERMANOVA, and sensitivity analyses. Results All HTLV-1 sequences belonged to the Cosmopolitan subtype, Transcontinental subgroup (HTLV-1aA; n = 27), whereas HTLV-2 segregated into three co-circulating subtypes: 2a (n = 1), 2b (n = 4) and 2c (n = 8). After correction for multiple testing, five mediators were higher in carriers than in controls, with moderate to large effect sizes (CCL5, IL-13, CXCL10, IL-18 and IL-4) and no growth factor differed. CCL5, CXCL10 and IL-13 were elevated in both viral types and IL-18 in HTLV-2 only, but no mediator differed between HTLV-1 and HTLV-2. Carriers also showed increased network connectivity among chemokines and type 1 and type 2 cytokines, and a significant global shift in mediator composition (PERMANOVA R² = 0.047, p = 0.002). Conclusion Our findings reveal the co-circulation of three HTLV-2 subtypes in Amazonas and a distinct circulating immune mediator profile in asymptomatic carriers, mainly driven by CCL5, CXCL10 and IL-13. Molecular surveillance should therefore extend into structured clinical follow-up, as asymptomatic infection does not imply immunological quiescence.
Authors
- Jean de Melo Silva (ORCID: https://orcid.org/0000-0002-2408-6983)
- Gemilson Soares Pontes (ORCID: https://orcid.org/0000-0001-9001-7954)
- Giselle Moura Guimarães-Marques (ORCID: https://orcid.org/0000-0002-9944-3586)
- Dayane Andriotti Otta (ORCID: https://orcid.org/0000-0002-3341-4053)
- Andréa Teixeira‐Carvalho (ORCID: https://orcid.org/0000-0003-2814-5183)
- Fernanda Khouri Barreto (ORCID: https://orcid.org/0000-0002-0088-9036)
- Jacqueline da Silva Batista (ORCID: https://orcid.org/0000-0002-6649-6200)
- Luíz Carlos Júnior Alcântara (ORCID: https://orcid.org/0000-0002-6769-9931)
- Natália Rocha Guimarães (ORCID: https://orcid.org/0000-0002-9859-5895)
- Uzamôr Henrique Soares Pessoa
- Felipe Araujo Santos
- Victória Karoline da Silva Araújo (ORCID: https://orcid.org/0009-0006-2307-6632)
- Kerollayne Costa da Silva
- ALLYSON GUIMARÃES COSTA
Institutions
- Universidade Federal da Bahia (BR)
- Instituto Nacional de Pesquisas da Amazônia (BR)
- Fiocruz Minas (BR)
- Universidade Federal do Amazonas (BR)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11586379/v1
- Primary Topic
- T-cell and Retrovirus Studies
- Type
- preprint
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação de Amparo à Pesquisa do Estado do Amazonas
- Instituto Nacional de Pesquisas da Amazônia
- Centro Nacional de Pesquisa em Energia e Materiais